OpenEvidence 獲 Thrive 和 DST 領投新一輪融資，估值達 120 億美元

Topics

Latest

AI

Amazon

Apps

Biotech & Health

Climate

Cloud Computing

Commerce

Crypto

Enterprise

EVs

Fintech

Fundraising

Gadgets

Gaming

Google

Government & Policy

Hardware

Instagram

Layoffs

Media & Entertainment

Meta

Microsoft

Privacy

Robotics

Security

Social

Space

Startups

TikTok

Transportation

Venture

More from TechCrunch

Staff

Events

Startup Battlefield

StrictlyVC

Newsletters

Podcasts

Videos

Partner Content

TechCrunch Brand Studio

Crunchboard

Contact Us

Posted:

OpenEvidence hits $12B valuation, with new round led by Thrive, DST

VCs who have backed OpenEvidence are apparently not worried about OpenAI and Anthropic’s new health information products.

On Wednesday, the startup announced that it raised an additional $250 million in Series D funding at a $12 billion valuation, co-led by Thrive Capital and DST.

That’s double the valuation from its last raise in October: $200 million at $6 billion, led by GV. It has now raised a total of $700 million, the company says, from backers including Sequoia, Nvidia, Kleiner Perkins, Blackstone, Bond, Craft Ventures, Mayo Clinic, and others.

OpenEvidence is an AI-powered medical information platform, similar to what WebMD was for the previous internet generation, but it’s geared toward doctors. This puts it somewhat more in competition with Anthropic’s Claude for Healthcare, which is intended for patients, payers and providers, whereas ChatGPT’s new health product is aimed more at consumers.

The company says that the free, ad-supported platform served 18 million clinical consultations from verified healthcare professionals in the U.S. in December alone. That compares to about 3 million searches per month a year ago.  It also said that it had surpassed $100 million in revenue.

Topics

Plan ahead for the 2026 StrictlyVC events. Hear straight-from-the-source candid insights in on-stage fireside sessions and meet the builders and backers shaping the industry. Join the waitlist to get first access to the lowest-priced tickets and important updates.

Newsletters

Subscribe for the industry’s biggest tech news

Every weekday and Sunday, you can get the best of TechCrunch’s coverage.

TechCrunch Mobility is your destination for transportation news and insight.

Startups are the core of TechCrunch, so get our best coverage delivered weekly.

Provides movers and shakers with the info they need to start their day.

By submitting your email, you agree to our Terms and Privacy Notice.

Related

Threads rolls out ads to all users worldwide

YouTube TV’s multiview is getting a huge upgrade, letting viewers mix and match channels

We’re not nostalgic for 2016 — we’re nostalgic for the internet before all the slop

Latest in Biotech & Health

OpenEvidence hits $12B valuation, with new round led by Thrive, DST

Why Serve Robotics is acquiring a hospital assistant robot company

BioticsAI, which won Disrupt’s Battlefield competition in 2023, gains FDA approval for its AI-powered fetal ultrasound product

© 2025 TechCrunch Media LLC.